{"id":40692,"date":"2015-08-07T08:23:56","date_gmt":"2015-08-07T12:53:56","guid":{"rendered":"http:\/\/piel-l.org\/blog\/?p=40692"},"modified":"2015-08-07T15:50:28","modified_gmt":"2015-08-07T20:20:28","slug":"omalizumab-for-previously-treated-chronic-spontaneous-urticarial","status":"publish","type":"post","link":"https:\/\/piel-l.org\/blog\/40692","title":{"rendered":"Omalizumab for previously treated chronic spontaneous urticarial"},"content":{"rendered":"","protected":true},"excerpt":{"rendered":"","protected":true},"author":16,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[48],"tags":[],"class_list":["post-40692","post","type-post","status-publish","format-standard","post-password-required","","category-comunicaciones-importantes"],"_links":{"self":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/40692","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/comments?post=40692"}],"version-history":[{"count":0,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/40692\/revisions"}],"wp:attachment":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/media?parent=40692"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/categories?post=40692"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/tags?post=40692"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}